Do you want to read an article? Please log in or register.
Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections
Asthma
Related content
RECOMMENDED
Bronchi
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
Lancet Respir Med.
Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE
doi: 10.1016/S2213-2600(18)30427-2.
Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis
Thorax.
Rayment JH, Stanojevic S, Davis SD, Retsch-Bogart G, Ratjen F
doi: 10.1136/
Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study
Infection.
Deppisch C, Herrmann G, Graepler-Mainka U, Wirtz H, Heyder S, Engel C, Marschal M, Miller CC, Riethmüller J
doi: 10.1007/s15010-016-0879-x.
RECOMMENDED
Bronchi
Infection prevention and chronic disease management in cystic fibrosis and noncystic fibrosis bronchiectasis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Ther Adv Respir Dis.
Lommatzsch ST
doi: 10.1177/1753466620905272.
RECOMMENDED
Pulmonary Fibrosis
Clinical characteristics and outcomes associated with Inquilinus infection in cystic fibrosis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Lenhart-Pendergrass PM, Caverly LJ, Wagner BD, Sagel SD, Nick JA, LiPuma JJ, Martiniano SL
doi: 10.1016/j.jcf.2020.07.011.
Pulmonary FibrosisPneumonia
Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis
Mycopathologia.
Schwarz C, Hartl D, Eickmeier O, Hector A, Benden C, Durieu I, Sole A, Gartner S, Milla CE, Barry PJ
doi: 10.1007/s11046-017-0182-0.
RECOMMENDED
Pulmonary Fibrosis
Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis
J Cyst Fibros.
Bilton D, Pressler T, Fajac I, Clancy JP, Sands D, Minic P, Cipolli M, Galeva I, Solé A, Quittner AL, Liu K, McGinnis JP 2nd, Eagle G, Gupta R, Konstan MW, CLEAR-108 Study Group.
doi: 10.1016/j.jcf.2019.08.001.
RECOMMENDED
Pulmonary Fibrosis
Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatment
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
VanDevanter DR, Heltshe SL, Sanders DB, West NE, Skalland M, Flume PA, Goss CH, STOP-OB Study.
doi: 10.1016/j.jcf.2020.08.006.
Pulmonary Fibrosis
Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV1) in cystic fibrosis patients receiving ivacaftor treatment
J Cyst Fibros.
Nagy B Jr, Bene Z, Fejes Z, Heltshe SL, Reid D, Ronan NJ, McCarthy Y, Smith D, Nagy A, Joseloff E, Balla G, Kappelmayer J, Macek M Jr, Bell SC, Plant BJ, Amaral MD, Balogh I
doi: 10.1016/j.jcf.2018.08.013.